Michael Hreczuck

Michael Hreczuck is a seasoned professional with extensive experience in business development and strategic partnerships within the life sciences and oncology sectors. Currently serving as the Global VP of Pharma Business Development at Lunit since September 2022, Michael drives initiatives in cancer diagnostics and therapeutics through AI solutions. Prior to this role, significant positions included Sr. Director of Business Development at Tempus Labs, Inc., where Michael advanced precision medicine through genomic data integration, and Senior Managing Director at Life Science-Bio Consulting, focusing on market intelligence in clinical diagnostics and trials. Michael's career also features senior roles at HTG Molecular Diagnostics and Aushon BioSystems, where Michael managed strategic alliances and global commercial operations, respectively, alongside earlier positions that involved sales and account management in the healthcare industry. Michael holds degrees from Massachusetts College of Pharmacy and Health Sciences and UMass Boston.